Read inspiring stories from survivors benefiting from research-driven advances against cancer, like brain cancer survivor Lanette Veres of Cave Creek, Arizona.
Read MoreThanks to spectacular research-driven advances, more than 18 million people in the United States and millions more worldwide are cancer survivors living with, through, and beyond their disease.
Learn MoreWhat is Cancer Precision Medicine? Research has powered an explosion in our understanding of the biology of cancer genomics and is leading to tailored treatments for patients.
Read the ReportMore than 106,000 people in the U.S. are expected to be diagnosed with melanoma this year. May is Melanoma and Skin Cancer Awareness Month. Learn more about the prevention, screening, and treatment options.
Learn MoreMaking Treatment Decisions: Abigail Johnston shares how she has approached decisions about her cancer care since she was diagnosed with metastatic breast cancer in 2017.
Read Practical KnowledgeThe Week in Cancer News: A roundup of significant cancer research news from the past week, selected by the staff of Cancer Today magazine.
Learn MoreWhether honoring a special person or a special day, a donation to the American Association for Cancer Research has a lasting impact.
Donate NowThe official news website of the AACR Annual Meeting 2024. Stay up to date on the latest developments from the most important cancer meeting in the world.
The AACR Cancer Progress Report 2023 provides a comprehensive overview of the latest research-driven advances against the collection of devastating diseases called cancer.
Learn MoreThe AACR and its more than 58,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreA new wave of research-driven discoveries and technological innovations are delivering – and will propel additional – transformative advances to save more lives from cancer..
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2020
Learn Moretherapeutics were approved for new or expanded uses by the FDA from Aug. 1, 2022, to July 31, 2023
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn More